DERMATA THERAPEUTICS, INC. — Income Charts
9 quarters of history · ending 2023-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+331.8% +$71K
$93K
R&D↓-41.9% -$650K
$903K
SG&A
—
D&A
$0
Operating Income↑+25.9% +$634K
$-2M
EBITDA↑+25.9% +$634K
$-2M
Interest Expense
$0
Interest Income
—
Tax Provision
$0
Net Income↑+29.1% +$705K
$-2M
Operating Margin↑+9431.2pts
-1953.3%
Net Margin↑+9431.2pts
-1853.3%
ETR Federal Statutory
—
ETR State + Local (pp)
—
Revenue YoY Variation↓-2868.7pts
331.8%
Income YoY Variation↑+68.8pts
25.9%
Revenue QoQ Variation
198.8%
Income QoQ Variation↓-15.0pts
-4.6%